• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于不同比对方法的抗结核胸苷单磷酸激酶抑制剂的3D-QSAR研究

3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.

作者信息

Aparna V, Jeevan J, Ravi M, Desiraju G R, Gopalakrishnan B

机构信息

School of Chemistry, University of Hyderabad, Hyderabad 500 046, India.

出版信息

Bioorg Med Chem Lett. 2006 Feb 15;16(4):1014-20. doi: 10.1016/j.bmcl.2005.10.086. Epub 2005 Nov 15.

DOI:10.1016/j.bmcl.2005.10.086
PMID:16290929
Abstract

Three dimensional quantitative structure-activity relationship (3D-QSAR) studies were carried out on deoxythymidine monophosphate (dTMP) derivatives inhibiting thymidine monophosphate kinase (TMPK) in Mycobacterium tuberculosis. Molecular field analysis (MFA) models with three different alignment techniques, namely, least squares, pharmacophore based and receptor based methods were developed. Receptor based MFA model showed better results when compared with least squares and pharmacophore based models. The results help us to understand the nature of substituents required for activity and thereby provide guidelines to design novel and potent inhibitors as antitubercular agents.

摘要

对结核分枝杆菌中抑制胸苷一磷酸激酶(TMPK)的脱氧胸苷一磷酸(dTMP)衍生物进行了三维定量构效关系(3D-QSAR)研究。开发了具有三种不同比对技术的分子场分析(MFA)模型,即最小二乘法、基于药效团的方法和基于受体的方法。与最小二乘法和基于药效团的模型相比,基于受体的MFA模型显示出更好的结果。这些结果有助于我们了解活性所需取代基的性质,从而为设计新型高效的抗结核药物抑制剂提供指导。

相似文献

1
3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.基于不同比对方法的抗结核胸苷单磷酸激酶抑制剂的3D-QSAR研究
Bioorg Med Chem Lett. 2006 Feb 15;16(4):1014-20. doi: 10.1016/j.bmcl.2005.10.086. Epub 2005 Nov 15.
2
Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.5'-硫脲取代的α-胸苷类似物作为分枝杆菌胸苷酸激酶抑制剂的合理设计与3D药效团映射
J Chem Inf Model. 2009 Apr;49(4):1070-8. doi: 10.1021/ci8004622.
3
A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.基于对接和药效团模型的胸苷一磷酸激酶抑制剂作为抗结核药物的虚拟筛选方法。
J Chem Inf Model. 2005 Jul-Aug;45(4):1101-8. doi: 10.1021/ci050064z.
4
3'-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.3'-C-支链取代核苷和核苷酸作为结核分枝杆菌胸苷单磷酸激酶的有效抑制剂。
J Med Chem. 2003 Aug 28;46(18):3811-21. doi: 10.1021/jm021108n.
5
Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.双环胸苷类似物作为结核分枝杆菌胸苷单磷酸激酶的选择性高亲和力抑制剂的发现。
J Med Chem. 2004 Dec 2;47(25):6187-94. doi: 10.1021/jm040847w.
6
Three-dimensional quantitative structure-activity relationship studies on c-Src inhibitors based on different docking methods.基于不同对接方法的c-Src抑制剂的三维定量构效关系研究
Chem Biol Drug Des. 2009 Apr;73(4):416-27. doi: 10.1111/j.1747-0285.2009.00789.x.
7
3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.作为HIV-1蛋白酶抑制剂的色酮衍生物的3D-QSAR研究:分子场分析的应用
Arch Pharm (Weinheim). 2008 Jun;341(6):357-64. doi: 10.1002/ardp.200700229.
8
Pharmacophore optimization and design of competitive inhibitors of thymidine monophosphate kinase through molecular modeling studies.通过分子建模研究对胸苷一磷酸激酶竞争性抑制剂的药效团优化和设计。
Chem Biol Drug Des. 2011 Nov;78(5):826-34. doi: 10.1111/j.1747-0285.2011.01200.x. Epub 2011 Sep 20.
9
3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents.基于胸苷的 TMPK 抑制剂的 3D 药效团映射作为潜在的抗结核药物。
J Comput Aided Mol Des. 2010 Feb;24(2):157-72. doi: 10.1007/s10822-010-9323-y. Epub 2010 Mar 10.
10
Synthesis and evaluation of thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.胸苷-5'-O-单磷酸类似物作为结核分枝杆菌胸苷酸激酶抑制剂的合成与评价
Bioorg Med Chem Lett. 2002 Oct 7;12(19):2695-8. doi: 10.1016/s0960-894x(02)00551-6.

引用本文的文献

1
Structural and chemical basis for enhanced affinity to a series of mycobacterial thymidine monophosphate kinase inhibitors: fragment-based QSAR and QM/MM docking studies.结构和化学基础增强了一系列分枝杆菌胸苷一磷酸激酶抑制剂的亲和力:基于片段的定量构效关系和 QM/MM 对接研究。
J Mol Model. 2013 Jan;19(1):179-92. doi: 10.1007/s00894-012-1527-8. Epub 2012 Jul 31.
2
A combined molecular modeling study on a series of pyrazole/isoxazole based human Hsp90α inhibitors.基于一系列吡唑/异噁唑的人热休克蛋白 90α 抑制剂的联合分子建模研究。
J Mol Model. 2011 Dec;17(12):3241-50. doi: 10.1007/s00894-011-1011-x. Epub 2011 Mar 4.
3
Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.
用于结核病药物发现的计算数据库、途径和化学信息学工具。
Trends Microbiol. 2011 Feb;19(2):65-74. doi: 10.1016/j.tim.2010.10.005. Epub 2010 Dec 2.
4
3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents.基于胸苷的 TMPK 抑制剂的 3D 药效团映射作为潜在的抗结核药物。
J Comput Aided Mol Des. 2010 Feb;24(2):157-72. doi: 10.1007/s10822-010-9323-y. Epub 2010 Mar 10.